Home » Authors » Trista Morrison

Trista Morrison

Articles

ARTICLES

Pozen Plummets On Second Approvable Letter For Trexima

Aug. 3, 2007

By Trista Morrison

Diagnostic Lab Firm Genoptix Files for $86.25 Million IPO

Aug. 2, 2007

By Trista Morrison

Diagnostic Lab Firm Genoptix Files for $86.25 Million IPO

Aug. 2, 2007

By Trista Morrison

Neuren Acquires Hamilton, Gets Phase II CNS Drug

Aug. 1, 2007

By Trista Morrison

Neuren Acquires Hamilton, Gets Phase II CNS Drug

Aug. 1, 2007

By Trista Morrison

Alnylam, Medtronic Expand Deal With RNAi Drug-Device Combos

July 31, 2007

By Trista Morrison

Alnylam, Medtronic Expand Deal With RNAi Drug-Device Combos

July 31, 2007

By Trista Morrison

NewCo News: Nuon Hits The Ground Running With Funding License Deal

July 30, 2007

By Trista Morrison

NewCo News: Nuon Hits The Ground Running With Funding License Deal

July 30, 2007

By Trista Morrison

Aspreva Restructures, Plans To Look Beyond CellCept

July 27, 2007

By Trista Morrison

View All Articles by Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...